Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -120.00%-27.88M | ---- | -22.77%-12.67M | ---- | 58.70%-10.32M | ---- | 68.05%-24.99M | ---- | 69.49%-78.22M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 7.19%-1.43M | ---- | -909.15%-1.54M | ---- | -19.53%-153K | ---- | 20.00%-128K | ---- | -11.89%-160K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | -183.30%-3.65M | ---- | 435.86%4.38M | ---- | 441.84%817K |
| Impairment and provisions: | ---- | -73.73%2.31M | ---- | 430.24%8.79M | ---- | -72.73%1.66M | ---- | -65.30%6.08M | ---- | -84.23%17.51M |
| -Impairmen of inventory (reversal) | ---- | -18.89%2.58M | ---- | 20.66%3.18M | ---- | 88.75%2.63M | ---- | -82.24%1.4M | ---- | -73.33%7.86M |
| -Impairment of trade receivables (reversal) | ---- | -104.80%-269K | ---- | 674.69%5.61M | ---- | ---976K | ---- | ---- | ---- | -68.88%9.65M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.68M | ---- | ---- |
| Asset sale loss (gain): | ---- | -86.84%10K | ---- | -80.61%76K | ---- | --392K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -86.84%10K | ---- | -80.61%76K | ---- | --392K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -10.88%6.06M | ---- | -39.31%6.8M | ---- | 27.25%11.21M | ---- | -12.12%8.81M | ---- | -64.53%10.02M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | -46.55%287K | ---- | -72.97%537K | ---- | -89.16%1.99M |
| Financial expense | ---- | -69.00%615K | ---- | -50.08%1.98M | ---- | -14.61%3.97M | ---- | -6.98%4.65M | ---- | -33.44%5M |
| Special items | ---- | ---- | ---- | ---3.19M | ---- | ---- | ---- | -181.63%-2.08M | ---- | 154.58%2.55M |
| Operating profit before the change of operating capital | ---- | -8,635.71%-20.32M | ---- | -92.34%238K | ---- | 194.67%3.11M | ---- | 92.27%-3.28M | ---- | 61.36%-42.48M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 196.86%11M | ---- | -303.35%-11.36M | ---- | 159.58%5.58M | ---- | -149.56%-9.37M | ---- | 290.25%18.91M |
| Accounts receivable (increase)decrease | ---- | 139.78%5.6M | ---- | 23.89%-14.09M | ---- | -100.88%-18.51M | ---- | -934.23%-9.22M | ---- | -101.77%-891K |
| Accounts payable increase (decrease) | ---- | -204.47%-28.27M | ---- | 8,914.01%27.06M | ---- | -111.58%-307K | ---- | 192.98%2.65M | ---- | -155.37%-2.85M |
| prepayments (increase)decrease | ---- | 33.72%-3.09M | ---- | -459.04%-4.67M | ---- | -112.12%-835K | ---- | -75.38%6.89M | ---- | -64.30%27.98M |
| Cash from business operations | -27.11%49.42M | -1,146.41%-35.07M | 304.88%67.81M | 74.33%-2.81M | -67.91%16.75M | 11.11%-10.96M | 4,380.64%52.18M | -1,932.24%-12.33M | -110.33%-1.22M | -95.18%673K |
| Other taxs | ---137K | -1,102.22%-541K | ---- | ---45K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -27.31%49.29M | -1,145.72%-35.62M | 304.88%67.81M | 73.92%-2.86M | -67.91%16.75M | 11.11%-10.96M | 4,380.64%52.18M | -1,932.24%-12.33M | -110.33%-1.22M | -95.18%673K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -67.90%156K | -7.19%1.43M | 73.57%486K | 909.15%1.54M | 1,117.39%280K | 19.53%153K | -65.67%23K | -20.00%128K | --67K | 11.89%160K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50K | ---- |
| Purchase of fixed assets | 98.56%-2K | -103.48%-11.85M | 60.96%-139K | -770.70%-5.83M | 88.56%-356K | 89.04%-669K | ---3.11M | -108.90%-6.1M | ---- | 57.93%-2.92M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --45.99M | ---- | ---- | ---- | --8M |
| Net cash from investment operations | -55.62%154K | -143.40%-10.42M | 556.58%347K | -109.41%-4.28M | 97.54%-76K | 861.25%45.48M | -2,741.03%-3.09M | -214.03%-5.97M | --117K | -89.83%5.24M |
| Net cash before financing | -27.46%49.44M | -544.75%-46.04M | 308.81%68.15M | -120.69%-7.14M | -66.04%16.67M | 288.56%34.52M | 4,554.72%49.09M | -409.62%-18.31M | -109.34%-1.1M | -90.97%5.91M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 90.62%54.03M | -52.94%8M | 11.59%28.35M | -33.07%17M | -46.19%25.4M | -13.90%25.4M | 6.19%47.2M | -2.32%29.5M | -6.42%44.45M |
| Refund | -112.50%-17M | -44.05%-24.49M | 52.94%-8M | 67.57%-17M | 64.95%-17M | 0.57%-52.42M | -62.21%-48.5M | -16.38%-52.72M | 2.92%-29.9M | 29.77%-45.3M |
| Issuing shares | 116.67%40.18M | --18.03M | --18.54M | ---- | ---- | 51.89%11.84M | 52.81%11.84M | --7.8M | --7.75M | ---- |
| Interest paid - financing | 0.36%-273K | 48.31%-612K | -3.79%-274K | 52.96%-1.18M | 88.25%-264K | 24.87%-2.52M | 4.38%-2.25M | 5.45%-3.35M | -0.64%-2.35M | -7.62%-3.54M |
| Other items of the financing business | --8.06M | ---- | ---- | ---- | --47.65M | ---- | ---- | ---- | ---- | --5.39M |
| Net cash from financing operations | 69.19%30.91M | 361.97%46.94M | -61.45%18.27M | 157.43%10.16M | 450.95%47.39M | -1,550.37%-17.69M | -370.01%-13.5M | -207.63%-1.07M | 270.39%5M | 102.56%996K |
| Effect of rate | 198.24%1.73M | -2,392.31%-972K | -543.94%-1.76M | -122.03%-39K | 200.00%396K | 427.78%177K | 842.86%132K | -133.96%-54K | 100.64%14K | -92.11%159K |
| Net Cash | -7.03%80.35M | -70.01%906K | 34.91%86.42M | -82.04%3.02M | 80.00%64.06M | 186.82%16.82M | 812.75%35.59M | -380.50%-19.38M | -56.01%3.9M | -73.96%6.91M |
| Begining period cash | -0.17%39.66M | 8.12%39.72M | 8.12%39.72M | 86.13%36.74M | 86.13%36.74M | -49.61%19.74M | -49.61%19.74M | 22.01%39.17M | 22.01%39.17M | 803.01%32.1M |
| Cash at the end | -2.13%121.73M | -0.17%39.66M | 22.92%124.39M | 8.12%39.72M | 82.47%101.2M | 86.13%36.74M | 28.73%55.46M | -49.61%19.74M | 11.07%43.08M | 22.01%39.17M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.